Browsing by Author Central Clinical School: Melonoma & Skin Cancer Res. Inst.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 41  next >
Issue DateTitleAuthor(s)Citation
2016Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanomaCarlino, Matteo; Fogarty, Gerald; Guminski, Alexander; Hong, Angela; Kefford, Richard (Rick); Liniker, Elizabeth; Lo, Serigne; Long, Georgina; Menzies, Alexander Maxwel; Ramanujam, Sangeetha; Cooper, Adam; Kong, Benjamin; Wang, T. W.; Western Clinical School: Medicine (Westmead); Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Melonoma & Skin Cancer Res. Inst.; The George Institute for Global Health; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma, OncoImmunology, vol.5, 9, 2016,pp 1-7
2017Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumabCarlino, Matteo; Guminski, Alexander; Long, Georgina; Menzies, Alexander Maxwel; Park, John; Ramanujam, Sangeetha; Atkinson, V; Eroglu, Z; et al, Various; Johnson, Douglas B; Klein, O; McQuade, J; Shoushtari, A; Tsai, K. K.; Wong, Annie; Western Clinical School: Medicine (Westmead); Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab, Annals of Oncology, vol.28, 2, 2017,pp 368-376
2005Bisphosphonates for breast cancer.Pavlakis, Nick; Schmidt, Robert; Stockler, Martin; Northern Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; School of Public Health: NH&MRC Clinical Trials CentreBisphosphonates for breast cancer., Cochrane Database of Systematic Reviews, vol.0,(3),2005,pp CD003474-N/A
2013BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III MelanomaCampain, Anna; Carter, Candace; De Silva, Chitra; Gerega, Sebastien; Hersey, Peter; Kefford, Richard (Rick); Lai, Kenneth; Mann, Graham; Pianova, Svetlana; Pupo, Gulietta; Schramm, Sarah-Jane; Scolyer, Richard; Synnott, Catherine; Thompson, John; Wilmott, James; Yang, Yee (Jean); Mathematics & Statistics; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Melanoma Foundation; Biological Sciences; Northern Clinical School: Surgery; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Clinical Ophthal & Eye Health; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Central Clinical School: Pathology; RADS - Research Analytics & Data Strategy; Central Clinical School: Surgery; Central Clinical School: Surgery; Mathematics & StatisticsBRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma, The Journal of Investigative Dermatology, vol.133, 2, 2013,pp 509-517
2016BRAF(V600E) and NRAS(Q61L/Q61R) mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reportingCooper, Wendy Anne; Kakavand, Hojabr; Long, Georgina; O'Toole, Sandra; Saw, Robyn; Scolyer, Richard; Smith, Elisabeth; Walker, Emily; Wilmott, James; Yu, Bing; Lum, Trina; Selinger, Christina; Central Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Medicine; Medicine; Central Clinical School: Surgery; Central Clinical School: MedicineBRAF(V600E) and NRAS(Q61L/Q61R) mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting, Histopathology, vol.69, 4, 2016,pp 680-686
2013BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV DamageKakavand, Hojabr; Mann, Graham; Scolyer, Richard; Thompson, John; Behren, Andreas; Cebon, Jonathan Simon; Dobrovic, Alexander; Kelly, John; Li, Jason; Mar, Victoria; McArthur, Grant A.; McLean, Catriona; Papenfuss, Anthony Troy; Tothill, Richard W.; Wolfe, Rory; Wong, Stephen; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Central Clinical School: SurgeryBRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage, Clinical Cancer Research, vol.19, 17, 2013,pp 4589-4598
2015Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitorsCarlino, Matteo; Drummond, Martin John; Guminski, Alexander; Kefford, Richard (Rick); Lo, Serigne; Long, Georgina; Lyle, Megan; Menzies, Alexander Maxwel; Scolyer, Richard; Thompson, John; Wilmott, James; Chan, Matthew M K; Western Clinical School: Medicine (Westmead); School of Public Health: Public Health; Medicine Faculty Office; Western Clinical School: Westmead Institute for Medical Res; The George Institute for Global Health; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: SurgeryClinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors, Cancer, vol.121, 21, 2015,pp 3826-3835
2015Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signalingDe Paoli-Iseppi, Ricardo; Gallagher, Stuart; Gowrishankar, Kavitha; Gunatilake, Dilini; Heinemann, Anja; Hersey, Peter; Madore, Jason; Strbenac, Dario; Tiffen, Jessamy; Wilmott, James; Yang, Jean Yee Hwa; Cullinane, Carleen; McArthur, Grant A.; Prinjha, Rab; Smithers, Nicholas; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Mathematics & Statistics; Central Clinical School: Centenary Institute; Central Clinical School: Surgery; Mathematics & StatisticsCombining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling, Oncotarget, vol.6, 25, 2015,pp 21507-21521
2016Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision makingKakavand, Hojabr; Long, Georgina; Mann, Graham; Menzies, Alexander Maxwel; Pupo, Gulietta; Scolyer, Richard; Wilmott, James; De Paoli-Iseppi, Ricardo; Dias, Kerith-Rae; Dinger, Marcel; Hayward, Nicholas K; Johansson, Peter; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: The Sydney Cancer Centre; Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Pathology; Central Clinical School: SurgeryComparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making, Pathology, vol.48, 3, 2016,pp 261-266
2014Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomasKakavand, Hojabr; Kefford, Richard (Rick); Long, Georgina; O'Toole, Sandra; Scolyer, Richard; Thompson, John; Wilmott, James; Crainic, Oana; Lum, Trina; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Pathology; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: SurgeryConcordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas, Pathology, vol.46, 3, 2014,pp 193-198
2014Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanomaCarlino, Matteo; Hamilton, Anne; Haydu, Lauren; Kakavand, Hojabr; Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; O'Toole, Sandra; Scolyer, Richard; Thompson, John; Yu, Bing; Cooper, Wendy; Ng, C; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: MedicineCorrelation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma, British Journal of Cancer, vol.111, 2, 2014,pp 292-299
2015Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (<01 mm) Sentinel Lymph Node MetastasesMadore, Jason; Nieweg, Omgo; Scolyer, Richard; Thompson, John; Vilain, Ricardo; Wang, Shu; Wilmott, James; Holtkamp, Lodewijka H J; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Medicine; Central Clinical School: SurgeryDetailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (<01 mm) Sentinel Lymph Node Metastases, Annals of Surgical Oncology, vol.22, 9, 2015,pp 2972-2977
2017Dynamic changes in PD-L1 expression and immune infiltrates early during treatment predict response to PD-1 blockade in MelanomaCarlino, Matteo; Guminski, Alexander; Jakrot, Valerie; Kakavand, Hojabr; Kefford, Richard (Rick); Liniker, Elizabeth; Lo, Serigne; Long, Georgina; Madore, Jason; Menzies, Alexander Maxwel; Saw, Robyn; Scolyer, Richard; Thompson, John; Vilain, Ricardo; Wilmott, James; Cooper, Adam J.; Howle, Julie; Kong, Benjamin; Westmead Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Westmead Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: SurgeryDynamic changes in PD-L1 expression and immune infiltrates early during treatment predict response to PD-1 blockade in Melanoma, Clinical Cancer Research, vol.23, 17, 2017,pp 5024-5033
2014Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium studydeFazio, Anna; Madore, Jason; Bowtell, David D L; Clarke, B; Deen, Suha; et al, Various; Kobel, M; Lele, S; Menon, U; Morrison, C; Odunsi, Kunle; Pharoah, Paul D. P.; Ramus, Susan J.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Melonoma & Skin Cancer Res. Inst.Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study, British Journal of Cancer, vol.111, 12, 2014,pp 2297-2307
2015Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanomaCarlino, Matteo; Colebatch, Andrew; Hersey, Peter; Kakavand, Hojabr; Long, Georgina; Scolyer, Richard; Thompson, John; Wilmott, James; Shang, Ping; Western Clinical School: Medicine (Westmead); Medicine; Northern Clinical School: Surgery; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: SurgeryExpression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma, Modern Pathology, vol.28, 7, 2015,pp 884-894
2014Genetic and clinico-pathologic analysis of metastatic uveal melanomaHaydu, Lauren; Kakavand, Hojabr; Scolyer, Richard; Thompson, John; Asher, Marina; Griewank, Klaus; Hillen, Uwe; Moll, Iris; Murali, Rajmohan; Schadendorf, Dirk; Schilling, Bastian; Sucker, Antje; van de Nes, Johannes; Zimmer, Lisa; Central Clinical School: Surgery; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: Pathology; Central Clinical School: SurgeryGenetic and clinico-pathologic analysis of metastatic uveal melanoma, Modern Pathology, vol.27, 2, 2014,pp 175-183
2012A high-throughput panel for identifying clinically relevant mutation profiles in melanomaCarter, Candace; Mann, Graham; Pupo, Gulietta; Scolyer, Richard; Tembe, Varsha; Aoude, Lauren G; Dutton-Regester, Ken; et al, various; Hunt, Priscilla; Irwin, Darryl; Lanagan, Cathy; O'Connor, Linda; O'Rourke, Michael; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Central Clinical School: Pathology; Western Clinical School: Medicine (Westmead)A high-throughput panel for identifying clinically relevant mutation profiles in melanoma, Molecular Cancer Therapeutics, vol.11, 4, 2012,pp 888-897
2013Identification of new prognostic biomarkers for Stage III metastatic melanoma patientsKakavand, Hojabr; Mann, Graham; Scolyer, Richard; Thompson, John; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Central Clinical School: SurgeryIdentification of new prognostic biomarkers for Stage III metastatic melanoma patients, OncoImmunology, vol.2, 9, 2013,pp e25564-1-e25564-3
2014International Multi-institutional Management and Outcome of Melanoma Patients with Positive Sentinel Lymph Nodes in More than One Nodal BasinHaydu, Lauren; Taylor, Eletha; Thompson, John; Ariyan, Charlotte; Brady, Mary; Coit, Daniel G.; Frankel, Timothy; Kuk, Deborah; Melstrom, Laleh; Panageas, Katherine; Sabel, Michael S.; Central Clinical School: Surgery; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: SurgeryInternational Multi-institutional Management and Outcome of Melanoma Patients with Positive Sentinel Lymph Nodes in More than One Nodal Basin, Annals of Surgical Oncology, vol.21, 13, 2014,pp 4324-4329
2012Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of MelanomaKakavand, Hojabr; Scolyer, Richard; Thompson, John; Ceol, Craig; Dresser, Karen; et al, Various; Hu, Yeguang; Larson, Allison; Lian, Christine; Tan, Li; Wu, Feizhen; Xu, Wenqi; Xu, Yufei; Zhan, Qian; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: Pathology; Central Clinical School: SurgeryLoss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma, Cell, vol.150, 6, 2012,pp 1135-1146